HSINCHU, July 13, 2022 /PRNewswire/ — Amaran Biotechnology Inc., a subsidiary of Taiwan's OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling line and facilities, a first in Taiwan, has been completed. The new facility minimizes the risks of human factors affecting the quality of the pharmaceutical products, and substantially enhances their safety.

Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan During Bio Asia-Taiwan 2022 7/28-7/31 Nachricht finanzen.net comes via ChinaTechNews.com.